Papers using
Smad2
antibodies
more suppliers
Papers on
Smad2
Butein is a novel anti-adipogenic compound.Park et al., South Korea. In J Lipid Res, 06 Apr 2013
Small interfering RNA mediated silencing of STAT3 or SMAD2/3 blunted the inhibitory effects of butein on adipogenesis indicating that an interaction between two signaling pathways is required for the action of butein.
Evaluation of the prognostic value of pSMAD immunohistochemistry in colorectal cancer.Hardwick et al., Utrecht, Netherlands. In Eur J Cancer Prev, 17 Mar 2013
As activation of the BMP and TGF-β pathways leads to phosphorylation of SMAD1,5,8 and SMAD2,3, respectively, and both need SMAD4 for translocation to the nucleus, we aimed to investigate whether nuclear staining of pSMAD1,5,8 and pSMAD2, 3 can be used as predictive markers in CRC.
From tall to short: the role of TGFβ signaling in growth and its disorders.Cormier-Daire et al., Paris, France. In Am J Med Genet C Semin Med Genet, Sep 2012
We found an increased level of active TGFβ in the fibroblast medium from patients with FBN1 or ADAMTSL2 mutations and an enhanced phosphorylated SMAD2 level, allowing us to conclude at an enhanced TGFβ signaling in GD and AD.
[Colorectal oncogenesis].Maley et al., Paris, France. In Bull Cancer, 2010
These allelic losses are associated with mutations in TP53, APC, SMAD2 and SMAD4 genes.
More papers using
Smad2
antibodies